Europe Healthcare 3D Printing Market Size

Europe Healthcare 3D Printing Market Analysis

The Europe Healthcare 3D Printing Market is expected to register a CAGR of 15.4% during the forecast period.

COVID-19 had a significant impact on the studied market owing to the utility of diverse designs used in hospitals by patients and health workers. The use of 3D-printed devices, such as face shields, masks, valves, and nasopharyngeal swabs, was high, which positively impacted the market's growth. For instance, as per an April 2021 article, in the battle against COVID-19, 3D printer companies specializing in a range of services pivoted their technology and designs to support relief efforts, mass-producing medical products essential for providers in a pandemic. The market is estimated to show stable growth owing to the rising use of 3D printing for personalized medicine during the forecast period.

The growth factors, such as the incidence of road injuries and dental issues, along with the rising geriatric population in the Europe region, are also expected to contribute to the demand for healthcare 3D printing, thereby boosting the growth of the market during the forecast period.

Several factors, such as continuous technological advancements in 3D printing, rising public and private investments to develop new 3D printing technologies and applications, and acceptance of 3D-printed organs and implants, are fueling the demand of this market in the European region. According to the data published by OECD 2022 update, around 42 thousand road injuries were registered in Belgium, 323.1 thousand in United Kingdom, and 204.7 thousand in Italy in 2021. Such a huge burden of road accident injuries leads to bone fractures and creates the need for implants, thus driving the growth of the healthcare 3D printing market in the region.

Furthermore, according to the update from European Patent Office 2021, the European market accounts for 42% of the global market for dental implants. The European market is the largest, with an estimated 4 million implants sold per year. It is a relatively new and rapidly expanding application in healthcare. Thus, the increasing use of the implant in the European market drive market growth.

In addition, the technological advancements, expansions, mergers, and acquisitions by market players to enhance market share are offering new growth opportunities for existing market players and new entrants in the European region's global 3D printing medical devices market. For instance, in March 2021, Cellink launched the BIO MDX series, the next generation of bioprinters designed for high-throughput fabrication and precision 3D bioprinting for biomedical manufacturing, including biocompatible medical devices. The developments are estimated to expand the 3D printing market in Europe during the forecast period.

Thus the above-mentioned factors are expected to drive the growth of the market during the forecast period. However, the lack of trained professionals and the absence of specific regulatory guidelines are expected to restrain the growth of the market over the forecast period.